Are You Missing Patients Eligible for Genetic Testing?

90% of women with a hereditary risk of breast cancer have yet to be identified. CancerIQ can help breast centers start, run and grow a high-risk program.

CancerIQ
Oct 4, 2017

To identify a woman as a carrier only after she develops cancer is a failure of cancer prevention.” -Mary Claire King

Copy of Copy of HBOC Week 2017 (1)-1.png

Are you doing everything you can to help your patients detect breast cancer early?

  • An estimated 90% of unaffected BRCA carriers have yet to be identified and most at-risk women have yet to be tested.¹
  • This could amount to 11,477,635 unaffected women who are eligible for testing. 
  • While genetic testing has become much more accessible, many practices still don’t have the tools to identify the patients that need it the most.

 

This Breast Cancer Awareness Month, bring the power of genetics to your program with CancerIQ.

 

CancerIQ benefits-1

 

CancerIQ makes it easy for providers to offer cancer risk assessment services to every patient who walks through the door.

Get in touch

¹ Drohan B, Roche CA, Cusack JC Jr, et al: Hereditary breast and ovarian cancer and other hereditary syndromes: Using technology to identify carriers. Ann Surg Oncol 19:1732-1737, 2012

Similar posts

Best Practices

Making the Case for a High-Risk Breast Program

Health systems with top-tier high-risk breast program increase early detection, prevent costly late-stage cancer care, and improve survival rates.

Turner Sato Oct 19, 2021

Keep in touch

CancerIQ is proud to offer precision prevention news and learning opportunities to our clinical champion community. You don't have to be our customer to take advantage – subscribe to receive the content you care about.